RCMNY
COLL icon

Rubric Capital Management (New York)’s Collegium Pharmaceutical COLL Stock Holding History

Rubric Capital Management (New York)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Hold
1,279,611
– – 0.42% 60
2026
Q1 		$42.3M Sell
1,279,611
-216,825
-14% -$9.18M 0.45% 47
2025
Q4 		$69.3M Sell
1,496,436
-1,330,062
-47% -$55.6M 0.83% 31
2025
Q3 		$98.9M Sell
2,826,498
-331,245
-10% -$11.5M 1.12% 21
2025
Q2 		$93.4M Buy
3,157,743
+157,743
+5% +$4.5M 1.41% 22
2025
Q1 		$89.5M Buy
3,000,000
+650,000
+28% +$19.9M 1.6% 19
2024
Q4 		$67.3M Buy
2,350,000
+1,100,000
+88% +$36.4M 0.86% 23
2024
Q3 		$48.3M Sell
1,250,000
-1,083,500
-46% -$38.6M 0.79% 35
2024
Q2 		$75.1M Buy
2,333,500
+499,473
+27% +$17.3M 1.97% 14
2024
Q1 		$71.2M Sell
1,834,027
-924,226
-34% -$32.3M 2.1% 15
2023
Q4 		$84.9M Sell
2,758,253
-416,747
-13% -$10.4M 1.76% 8
2023
Q3 		$71M Sell
3,175,000
-250,000
-7% -$5.7M 2.66% 11
2023
Q2 		$73.6M Buy
3,425,000
+150,832
+5% +$3.42M 3.15% 10
2023
Q1 		$78.5M Sell
3,274,168
-59,460
-2% -$1.58M 2.04% 11
2022
Q4 		$77.3M Hold
3,333,628
– – 3.37% 5
2022
Q3 		$53.4M Buy
3,333,628
+75,000
+2% +$1.32M 2.69% 13
2022
Q2 		$57.7M Buy
3,258,628
+258,628
+9% +$4.35M 3.03% 9
2022
Q1 		$61.1M Buy
3,000,000
+393,500
+15% +$7.43M 2.21% 12
2021
Q4 		$48.7M Hold
2,606,500
– – 2.3% 17
2021
Q3 		$51.5M Buy
2,606,500
+186,286
+8% +$4.03M 1.44% 13
2021
Q2 		$57.2M Hold
2,420,214
– – 3.6% 6
2021
Q1 		$57.4M Buy
2,420,214
+493,931
+26% +$11.7M 3.35% 3
2020
Q4 		$38.6M Hold
1,926,283
– – 2.83% 12
2020
Q3 		$40.1M Hold
1,926,283
– – 3.74% 4
2020
Q2 		$33.7M Buy
1,926,283
+712,871
+59% +$14M 3.88% 4
2020
Q1 		$19.8M Buy
+1,213,412
New +$25M 3.13% 15

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Rubric Capital Management (New York)'s COLL Position: Q2 2026 in Review

Rubric Capital Management (New York) held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 1,279,611 shares worth $46.3M. The position accounts for 0.42% of the portfolio, ranked #60.

Rubric Capital Management (New York) first reported a position in COLL in Q1 2020 and has held it in 26 quarters since. The position peaked at $98.9M in Q3 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Rubric Capital Management (New York) held 1,279,611 shares of Collegium Pharmaceutical worth $46.3M as of Q2 2026.
  • Rubric Capital Management (New York) left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up 0.42% of Rubric Capital Management (New York)'s portfolio in Q2 2026, its #60 holding.
  • Rubric Capital Management (New York) first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Rubric Capital Management (New York)'s Collegium Pharmaceutical position peaked at $98.9M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.